Viracta Therapeutics Announces Chief Executive Officer Leadership Succession to Drive the Next Phase of the Company’s Strategic Development and Growth
- Monday, September 19, 2022, 7:13
- PR Newswire
- Add a comment
Viracta Therapeutics’ Board of Directors appoints Mark Rothera as President and Chief Executive Officer Founding President and CEO Ivor Royston, M.D., will continue to serve as a Member of Viracta’s Board of Directors SAN DIEGO, Sept. 19, 2022 /PRNewswire/ — Viracta Therapeutics, Inc….
About the Author
admin has written 20655 stories on this site.